# A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus

> **NCT04678557** · PHASE1,PHASE2 · TERMINATED · sponsor: **ViaCyte** · enrollment: 31 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **COMBINATION_PRODUCT:** VC-01 Combination Product

## Key facts

- **NCT ID:** NCT04678557
- **Lead sponsor:** ViaCyte
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-25
- **Primary completion:** 2021-11-12
- **Final completion:** 2021-11-19
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Insufficient functional product engraftment
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04678557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04678557, "A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04678557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*